https://molibresibinhibitor.co....m/distribution-of-as
Most of the patients were addressed with neurohormonal blockade, and a multi-disciplinary choice had been built to stop trabectedin in 3 clients and continue in 1 patient. Two for the 4 customers had an improvement in their left ventricular systolic function. It is unclear what impact preceeding anthracycline or tyrosine kinase inhibitor treatment features in priming customers to develop cardiotoxicity in this setting. Our case series adds to the evidence surrounding this connect
Like
Comment
Share
